Analysts Expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) To Breakeven Soon - simplywall.st
3 days ago • Google News
BioCryst Pharmaceuticals Inc (BCRX)
US$ 9.85-2.09%
Price Chart
Key Statistics
Market Cap
$ 1.66B
P/E Ratio
0.00
Revenue (TTM)
$ 503.48M
Volume
8.92M
52W High
$ 11.31
52W Low
$ 6.01
Dividend Yield
0.00%
Beta
1.04
Technicals
50-Day MA
9.5744
200-Day MA
8.3967
52 Week High
11.31
52 Week Low
6.015
About BCRX
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.
Employees
580
Headquarters
Durham, NC
CEO
Mr. Jon P. Stonehouse
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg